Sichetti Marzia, Giuseffi Martina, Giglio Eugenia, Marino Graziella, Mecca Marisabel
Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy.
Unit of Breast Cancer, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy.
Mol Nutr Food Res. 2025 Aug;69(16):e70055. doi: 10.1002/mnfr.70055. Epub 2025 Apr 7.
Breast cancer is the most common type of malignancy among women worldwide. Significant achievements have been made in diagnostic tools and cancer treatments in the past decade; however, the complexity and heterogeneity of certain breast cancer subtypes often lead to drug resistance and metastatic progression. Owing to their low toxicity and high variety, natural products and their derivatives are becoming increasingly valuable sources for small-molecule anticancer drugs. Polyphenols are becoming more widely known for their role in breast cancer prevention and as adjuvants in conventional treatment strategies. Therefore, this review focuses on the antitumor effects of curcumin, resveratrol, and polydatin on breast cancer. According to the main databases, only in vitro and preclinical studies with solid scientific backgrounds and reports of protective effects on breast cancer treatment were included. Curcumin, resveratrol, and polydatin have antioxidant, anti-inflammatory, and anticancer effects; indeed, they improve drug efficacy; reduce chemoresistance, angiogenesis, and tumor growth; and induce apoptosis, autophagy, and cell cycle arrest in breast cancer through multiple molecular pathways, including the suppression of epithelial-mesenchymal transition (EMT), NF-κB, PI3K/Akt/mTOR, c-Jun N-terminal kinase (JNK), MAPK, ERK1/2, and STAT signaling pathways; the inhibition of cyclins and matrix metalloproteinase (MMP)-2 and MMP-9; and the activation of p53 and microtubule-associated protein light chain 3 (LC3).
乳腺癌是全球女性中最常见的恶性肿瘤类型。在过去十年中,诊断工具和癌症治疗方面取得了重大进展;然而,某些乳腺癌亚型的复杂性和异质性常常导致耐药性和转移进展。由于其低毒性和高多样性,天然产物及其衍生物正日益成为小分子抗癌药物的宝贵来源。多酚因其在乳腺癌预防中的作用以及作为传统治疗策略中的佐剂而越来越广为人知。因此,本综述聚焦于姜黄素、白藜芦醇和虎杖苷对乳腺癌的抗肿瘤作用。根据主要数据库,仅纳入了具有坚实科学背景的体外和临床前研究以及对乳腺癌治疗具有保护作用的报告。姜黄素、白藜芦醇和虎杖苷具有抗氧化、抗炎和抗癌作用;实际上,它们提高药物疗效;降低化疗耐药性、血管生成和肿瘤生长;并通过多种分子途径诱导乳腺癌细胞凋亡、自噬和细胞周期停滞,这些途径包括抑制上皮-间质转化(EMT)、NF-κB、PI3K/Akt/mTOR、c-Jun氨基末端激酶(JNK)、MAPK、ERK1/2和STAT信号通路;抑制细胞周期蛋白以及基质金属蛋白酶(MMP)-2和MMP-9;以及激活p53和微管相关蛋白轻链3(LC3)。